Ramucirumab combined with paclitaxel as the second-line chemotherapy for elderly patients with disseminated gastric cancer

Gastric cancer is the third leading cause of cancer-related deaths worldwide. The prognosis of advanced gastric cancer remains poor despite therapeutic advances in recent decades. Several recent positive phase III trials established the efficacy of second-line chemotherapy for metastatic gastric can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: T. A. Titova, N. S. Besova, V. A. Gorbunova, R. N. Nasyrova, A. A. Fedenko
Formato: Artigo
Idioma:Russo
Publicado em: Remedium Group LLC 2018-07-01
Colecção:Медицинский совет
Assuntos:
advanced gastric cancer
second line chemotherapy
ramucirumab
paclitaxel
Acesso em linha:https://www.med-sovet.pro/jour/article/view/2553
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados